KoNECT And Its Remarkable Role in Korean Clinical Trials
In today’s interview, we’re speaking with Dr. In-seok Park, Ph.D., the esteemed President of KoNECT. Dr. Park, who assumed...
Moe Alsumidaie
FDA Needs To Release ClinicalTrials.gov Guidance Now
The 2024 Clinical Trials Transformation Initiative (CTTI) report, drawing on a broad spectrum of responses from diverse stakeholders in...
Latest Clinical Trial Tech Emerges: A Medidata NEXT Insight
At the 2023 Medidata NEXT conference, prominent figures like Michelle Hartman from South Broward Research, Adam Kinsey from Merck,...
Dubai’s Arab Health: Leading New Medical Advances
Join us at the Arab Health 2024 conference, set in the vibrant city of Dubai, from January 29 to...
Innovative DCT Leap: Bayer’s New OCEANIC Study
The Vanguard of Decentralized Clinical Trials: Bayer’s OCEANIC Study The Medidata NEXT conference spotlighted the groundbreaking OCEANIC study by...
Revolutionary Digital Twins: The Future of Clinical Trials
In this interview with Gian Carlo (GC) Ochoa, a leading figure in digital twins technology for clinical trials, we...
Cytonics CYT-108: A Unique Approach to OA Treatment
In this interview, we spoke with Joey Bose, President & CEO of Cytonics, diving into the intricacies of their...
FDA NIH & DARPA Government Agencies Lead New DCT Initiatives
In today’s discussion, we’re joined by Craig Lipset, Co-Chair of the Decentralized Trials & Research Alliance (DTRA), who shares...
Master Protocols: FDA New Flexible Approach in Cancer Trials
Master Protocols (MPs) mark a significant evolution in the realm of clinical research, especially notable in oncology. These protocols,...
A Great Divide: Sponsors Clash With FDA on Trial Data Excess
A new study, conducted collaboratively by the Tufts Center for the Study of Drug Development (Tufts CSDD), the FDA,...